FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Lehrstuhl für Innere Medizin I (Medizin 1)
Overview
Publications
(269)
Research Grants
(4)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment (2022)
Bouhnik Y, Atreya R, Casey D, Gorecki M, Baik D, Yoon SW, Kwon TS, Jang M
Journal article
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? (2022)
Monteleone G, Stolfi C, Marafini I, Atreya R, Neurath M
Journal article
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells (2022)
Schweda A, Becker E, Wiendl M, Atreya R, Atreya I, Müller T, Neurath M, Zundler S
Journal article
PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022)
Gerlach K, Popp V, Wirtz S, Al-Saifi R, Gonzalez Acera M, Atreya R, Dregelis T, et al.
Journal article
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis (2022)
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, et al.
Journal article, Review article
LONG-TERM HUMORAL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE (2022)
Tascilar K, Simon D, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al.
Conference contribution
Vedolizumab blocks alpha 4 beta 7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis (2022)
Besendorf L, Müller T, Geppert CI, Schneider I, Mühl L, Atreya I, Vitali F, et al.
Journal article
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets (2022)
Becker E, Schweda A, Ullrich K, Voskens C, Atreya R, Müller T, Atreya I, et al.
Journal article
Positionspapier zur Befunderhebung von Darmultraschallbefunden bei chronisch entzündlichen Darmerkrankungen (2022)
Kucharzik T, Atreya R, Bachmann O, Baumgart DC, Daebritz J, Helwig U, Janschek J, et al.
Journal article
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality (2022)
Atreya R, Neurath M
Journal article
‹
1
...
5
6
7
8
9
...
27
›